Back

Plasma CXCL8 and MCP-1 as biomarkers of latent tuberculosis infection

Selvavinayagam, S. T.; Aswathy, B.; Yong, Y. K.; Frederick, A.; Murali, L.; Kalaivani, V.; Jith, K. S.; Rajeshkumar, M.; Anusree, A.; Kannan, M.; Gopalan, N.; Vignesh, R.; Murugesan, A.; Tan, H. Y.; Zhang, Y.; Chandramathi, S.; Sivasankaran, M. P.; Govindaraj, S.; Byrareddy, S. N.; Velu, V.; Larsson, M.; Shankar, E. M.; Raju, S.

2023-08-09 infectious diseases
10.1101/2023.08.07.23293767 medRxiv
Show abstract

BackgroundEarly detection of latent tuberculosis infection (LTBI) is critical to TB elimination in the current WHO vision of End Tuberculosis Strategy. MethodsWe investigated whether detecting plasma cytokines could aid in diagnosing LTBI across household contacts (HHCs) positive for IGRA, HHCs negative for IGRA, and healthy controls. We also measured the plasma cytokines using a commercial Bio-Plex Pro Human Cytokine 17-plex assay. ResultsIncreased plasma CXCL8 and decreased MCP-1, TNF-, and IFN-{gamma} were associated with LTBI. Regression analysis showed that a combination of CXCL8 and MCP-1 increased the risk of LTBI among HHCs to 14-fold. ConclusionsWe postulated that CXCL8 and MCP-1 could be the surrogate biomarkers of LTBI, especially in resource-limited settings.

Matching journals

The top 8 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.